{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Stefanadis C, Synetos A, Tousoulis D, Tsiamis E, Michelongona A, Zagouri F, Bamias A, Dimopoulos MA, Kyvelou S, Kapelakis I, et al. Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer. International Journal of Cardiology [Internet]. 2012;154(3):341 - 344.\par \par }